 | • レポートコード：MRC2-11QY01682 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は吸入可能薬のグローバル市場について調査・分析したレポートです。種類別（懸濁液エアゾール、溶液エアゾール、乾燥粉末製剤）市場規模、用途別（呼吸器疾患、非呼吸器疾患）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別吸入可能薬の競争状況、市場シェア ・世界の吸入可能薬市場：種類別市場規模 2015年-2020年（懸濁液エアゾール、溶液エアゾール、乾燥粉末製剤） ・世界の吸入可能薬市場：種類別市場規模予測 2021年-2026年（懸濁液エアゾール、溶液エアゾール、乾燥粉末製剤） ・世界の吸入可能薬市場：用途別市場規模 2015年-2020年（呼吸器疾患、非呼吸器疾患） ・世界の吸入可能薬市場：用途別市場規模予測 2021年-2026年（呼吸器疾患、非呼吸器疾患） ・北米の吸入可能薬市場分析：米国、カナダ ・ヨーロッパの吸入可能薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの吸入可能薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の吸入可能薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの吸入可能薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：NanoDerma、Pfizer、Aradigm Corporation、Alkerme、Dura Pharmaceuticals、AeroGen and Inhale Therapeutic Systems ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Inhalable drugs are medicines that inhaled directly into lungs to achieve higher curing efficiency.
Global inhalable drugs market is expected to witness a lucrative market growth over the forecast period owing to rising prevalence of chronic diseases such as diabetes mellitus, tuberculosis, cancer and increasing geriatric population base which requires more convenient route of administration.
Market Analysis and Insights: Global Inhalable Drugs Market
The global Inhalable Drugs market size is projected to reach US$ 22670 million by 2026, from US$ 21830 million in 2020, at a CAGR of 3.6%% during 2021-2026.
Global Inhalable Drugs Scope and Market Size
Inhalable Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Inhalable Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Inhalable Drugs market is segmented into
Suspension Aerosol
Solution Aerosol
Dry Powder Formulation
Segment by Application, the Inhalable Drugs market is segmented into
Respiratory diseases
Non-respiratory diseases
Regional and Country-level Analysis
The Inhalable Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Inhalable Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Inhalable Drugs Market Share Analysis
Inhalable Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Inhalable Drugs business, the date to enter into the Inhalable Drugs market, Inhalable Drugs product introduction, recent developments, etc.
The major vendors covered:
NanoDerma
Pfizer
Aradigm Corporation
Alkerme
Dura Pharmaceuticals
AeroGen and Inhale Therapeutic Systems
…
1 Study Coverage
1.1 Inhalable Drugs Product Introduction
1.2 Market Segments
1.3 Key Inhalable Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Inhalable Drugs Market Size Growth Rate by Type
1.4.2 Suspension Aerosol
1.4.3 Solution Aerosol
1.4.4 Dry Powder Formulation
1.5 Market by Application
1.5.1 Global Inhalable Drugs Market Size Growth Rate by Application
1.5.2 Respiratory diseases
1.5.3 Non-respiratory diseases
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Inhalable Drugs Market Size, Estimates and Forecasts
2.1.1 Global Inhalable Drugs Revenue 2015-2026
2.1.2 Global Inhalable Drugs Sales 2015-2026
2.2 Global Inhalable Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Inhalable Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Inhalable Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Inhalable Drugs Competitor Landscape by Players
3.1 Inhalable Drugs Sales by Manufacturers
3.1.1 Inhalable Drugs Sales by Manufacturers (2015-2020)
3.1.2 Inhalable Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Inhalable Drugs Revenue by Manufacturers
3.2.1 Inhalable Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Inhalable Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Inhalable Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Inhalable Drugs Revenue in 2019
3.2.5 Global Inhalable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Inhalable Drugs Price by Manufacturers
3.4 Inhalable Drugs Manufacturing Base Distribution, Product Types
3.4.1 Inhalable Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Inhalable Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Inhalable Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Inhalable Drugs Market Size by Type (2015-2020)
4.1.1 Global Inhalable Drugs Sales by Type (2015-2020)
4.1.2 Global Inhalable Drugs Revenue by Type (2015-2020)
4.1.3 Inhalable Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Inhalable Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Inhalable Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Inhalable Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Inhalable Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Inhalable Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Inhalable Drugs Market Size by Application (2015-2020)
5.1.1 Global Inhalable Drugs Sales by Application (2015-2020)
5.1.2 Global Inhalable Drugs Revenue by Application (2015-2020)
5.1.3 Inhalable Drugs Price by Application (2015-2020)
5.2 Inhalable Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Inhalable Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Inhalable Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Inhalable Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Inhalable Drugs by Country
6.1.1 North America Inhalable Drugs Sales by Country
6.1.2 North America Inhalable Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Inhalable Drugs Market Facts & Figures by Type
6.3 North America Inhalable Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Inhalable Drugs by Country
7.1.1 Europe Inhalable Drugs Sales by Country
7.1.2 Europe Inhalable Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Inhalable Drugs Market Facts & Figures by Type
7.3 Europe Inhalable Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Inhalable Drugs by Region
8.1.1 Asia Pacific Inhalable Drugs Sales by Region
8.1.2 Asia Pacific Inhalable Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Inhalable Drugs Market Facts & Figures by Type
8.3 Asia Pacific Inhalable Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Inhalable Drugs by Country
9.1.1 Latin America Inhalable Drugs Sales by Country
9.1.2 Latin America Inhalable Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Inhalable Drugs Market Facts & Figures by Type
9.3 Central & South America Inhalable Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Inhalable Drugs by Country
10.1.1 Middle East and Africa Inhalable Drugs Sales by Country
10.1.2 Middle East and Africa Inhalable Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Inhalable Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Inhalable Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 NanoDerma
11.1.1 NanoDerma Corporation Information
11.1.2 NanoDerma Description and Business Overview
11.1.3 NanoDerma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 NanoDerma Inhalable Drugs Products Offered
11.1.5 NanoDerma Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description and Business Overview
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Inhalable Drugs Products Offered
11.2.5 Pfizer Related Developments
11.3 Aradigm Corporation
11.3.1 Aradigm Corporation Corporation Information
11.3.2 Aradigm Corporation Description and Business Overview
11.3.3 Aradigm Corporation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Aradigm Corporation Inhalable Drugs Products Offered
11.3.5 Aradigm Corporation Related Developments
11.4 Alkerme
11.4.1 Alkerme Corporation Information
11.4.2 Alkerme Description and Business Overview
11.4.3 Alkerme Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Alkerme Inhalable Drugs Products Offered
11.4.5 Alkerme Related Developments
11.5 Dura Pharmaceuticals
11.5.1 Dura Pharmaceuticals Corporation Information
11.5.2 Dura Pharmaceuticals Description and Business Overview
11.5.3 Dura Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Dura Pharmaceuticals Inhalable Drugs Products Offered
11.5.5 Dura Pharmaceuticals Related Developments
11.6 AeroGen and Inhale Therapeutic Systems
11.6.1 AeroGen and Inhale Therapeutic Systems Corporation Information
11.6.2 AeroGen and Inhale Therapeutic Systems Description and Business Overview
11.6.3 AeroGen and Inhale Therapeutic Systems Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AeroGen and Inhale Therapeutic Systems Inhalable Drugs Products Offered
11.6.5 AeroGen and Inhale Therapeutic Systems Related Developments
11.1 NanoDerma
11.1.1 NanoDerma Corporation Information
11.1.2 NanoDerma Description and Business Overview
11.1.3 NanoDerma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 NanoDerma Inhalable Drugs Products Offered
11.1.5 NanoDerma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Inhalable Drugs Market Estimates and Projections by Region
12.1.1 Global Inhalable Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Inhalable Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Inhalable Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Inhalable Drugs Sales Forecast (2021-2026)
12.2.2 North America: Inhalable Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Inhalable Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Inhalable Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Inhalable Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Inhalable Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Inhalable Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Inhalable Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Inhalable Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Inhalable Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Inhalable Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Inhalable Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Inhalable Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Inhalable Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Inhalable Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Inhalable Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Inhalable Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Inhalable Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Inhalable Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Inhalable Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Inhalable Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Inhalable Drugs Market Segments
Table 2. Ranking of Global Top Inhalable Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Inhalable Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Suspension Aerosol
Table 5. Major Manufacturers of Solution Aerosol
Table 6. Major Manufacturers of Dry Powder Formulation
Table 7. Global Inhalable Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Inhalable Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Inhalable Drugs Sales by Regions 2015-2020 (K Units)
Table 10. Global Inhalable Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Inhalable Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Inhalable Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Inhalable Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Inhalable Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Inhalable Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inhalable Drugs as of 2019)
Table 16. Inhalable Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Inhalable Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Inhalable Drugs Price (2015-2020) (USD/Unit)
Table 19. Inhalable Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Inhalable Drugs Product Type
Table 21. Date of International Manufacturers Enter into Inhalable Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Inhalable Drugs Sales by Type (2015-2020) (K Units)
Table 24. Global Inhalable Drugs Sales Share by Type (2015-2020)
Table 25. Global Inhalable Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Inhalable Drugs Revenue Share by Type (2015-2020)
Table 27. Inhalable Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Inhalable Drugs Sales by Application (2015-2020) (K Units)
Table 29. Global Inhalable Drugs Sales Share by Application (2015-2020)
Table 30. North America Inhalable Drugs Sales by Country (2015-2020) (K Units)
Table 31. North America Inhalable Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Inhalable Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Inhalable Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Inhalable Drugs Sales by Type (2015-2020) (K Units)
Table 35. North America Inhalable Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Inhalable Drugs Sales by Application (2015-2020) (K Units)
Table 37. North America Inhalable Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Inhalable Drugs Sales by Country (2015-2020) (K Units)
Table 39. Europe Inhalable Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Inhalable Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Inhalable Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Inhalable Drugs Sales by Type (2015-2020) (K Units)
Table 43. Europe Inhalable Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Inhalable Drugs Sales by Application (2015-2020) (K Units)
Table 45. Europe Inhalable Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Inhalable Drugs Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Inhalable Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Inhalable Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Inhalable Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Inhalable Drugs Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Inhalable Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Inhalable Drugs Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Inhalable Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Inhalable Drugs Sales by Country (2015-2020) (K Units)
Table 55. Latin America Inhalable Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Inhalable Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Inhalable Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Inhalable Drugs Sales by Type (2015-2020) (K Units)
Table 59. Latin America Inhalable Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Inhalable Drugs Sales by Application (2015-2020) (K Units)
Table 61. Latin America Inhalable Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Inhalable Drugs Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Inhalable Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Inhalable Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Inhalable Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Inhalable Drugs Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Inhalable Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Inhalable Drugs Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Inhalable Drugs Sales Market Share by Application (2015-2020)
Table 70. NanoDerma Corporation Information
Table 71. NanoDerma Description and Major Businesses
Table 72. NanoDerma Inhalable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. NanoDerma Product
Table 74. NanoDerma Recent Development
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Major Businesses
Table 77. Pfizer Inhalable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Pfizer Product
Table 79. Pfizer Recent Development
Table 80. Aradigm Corporation Corporation Information
Table 81. Aradigm Corporation Description and Major Businesses
Table 82. Aradigm Corporation Inhalable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Aradigm Corporation Product
Table 84. Aradigm Corporation Recent Development
Table 85. Alkerme Corporation Information
Table 86. Alkerme Description and Major Businesses
Table 87. Alkerme Inhalable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Alkerme Product
Table 89. Alkerme Recent Development
Table 90. Dura Pharmaceuticals Corporation Information
Table 91. Dura Pharmaceuticals Description and Major Businesses
Table 92. Dura Pharmaceuticals Inhalable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Dura Pharmaceuticals Product
Table 94. Dura Pharmaceuticals Recent Development
Table 95. AeroGen and Inhale Therapeutic Systems Corporation Information
Table 96. AeroGen and Inhale Therapeutic Systems Description and Major Businesses
Table 97. AeroGen and Inhale Therapeutic Systems Inhalable Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. AeroGen and Inhale Therapeutic Systems Product
Table 99. AeroGen and Inhale Therapeutic Systems Recent Development
Table 100. Global Inhalable Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 101. Global Inhalable Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 102. Global Inhalable Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 103. Global Inhalable Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 104. North America: Inhalable Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 105. North America: Inhalable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Europe: Inhalable Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 107. Europe: Inhalable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Asia Pacific: Inhalable Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 109. Asia Pacific: Inhalable Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 110. Latin America: Inhalable Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 111. Latin America: Inhalable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Middle East and Africa: Inhalable Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 113. Middle East and Africa: Inhalable Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 115. Key Challenges
Table 116. Market Risks
Table 117. Main Points Interviewed from Key Inhalable Drugs Players
Table 118. Inhalable Drugs Customers List
Table 119. Inhalable Drugs Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Inhalable Drugs Product Picture
Figure 2. Global Inhalable Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Suspension Aerosol Product Picture
Figure 4. Solution Aerosol Product Picture
Figure 5. Dry Powder Formulation Product Picture
Figure 6. Global Inhalable Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Respiratory diseases
Figure 8. Non-respiratory diseases
Figure 9. Inhalable Drugs Report Years Considered
Figure 10. Global Inhalable Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Inhalable Drugs Sales 2015-2026 (K Units)
Figure 12. Global Inhalable Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Inhalable Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Inhalable Drugs Sales Market Share by Region in 2019
Figure 15. Global Inhalable Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Inhalable Drugs Revenue Market Share by Region in 2019
Figure 17. Global Inhalable Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Inhalable Drugs Revenue in 2019
Figure 19. Inhalable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Inhalable Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Inhalable Drugs Sales Market Share by Type in 2019
Figure 22. Global Inhalable Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Inhalable Drugs Revenue Market Share by Type in 2019
Figure 24. Global Inhalable Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Inhalable Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Inhalable Drugs Sales Market Share by Application in 2019
Figure 27. Global Inhalable Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Inhalable Drugs Revenue Market Share by Application in 2019
Figure 29. North America Inhalable Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Inhalable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Inhalable Drugs Sales Market Share by Country in 2019
Figure 32. North America Inhalable Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Inhalable Drugs Market Share by Type in 2019
Figure 38. North America Inhalable Drugs Market Share by Application in 2019
Figure 39. Europe Inhalable Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Inhalable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Inhalable Drugs Sales Market Share by Country in 2019
Figure 42. Europe Inhalable Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Inhalable Drugs Market Share by Type in 2019
Figure 54. Europe Inhalable Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Inhalable Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Inhalable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Inhalable Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Inhalable Drugs Revenue Market Share by Region in 2019
Figure 59. China Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Inhalable Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Inhalable Drugs Market Share by Application in 2019
Figure 83. Latin America Inhalable Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Inhalable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Inhalable Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Inhalable Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Inhalable Drugs Market Share by Type in 2019
Figure 94. Latin America Inhalable Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Inhalable Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Inhalable Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Inhalable Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Inhalable Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Inhalable Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Inhalable Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Inhalable Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Inhalable Drugs Market Share by Application in 2019
Figure 107. North America Inhalable Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Inhalable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Inhalable Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Inhalable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Inhalable Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Inhalable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Inhalable Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Inhalable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Inhalable Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Inhalable Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
中枢神経系疾患治療薬の世界市場（～2026年） A drug used to treat neurological diseases that affect the functioning of the brain or spinal cord in the central nervous system Market Analysis and Insights: Global Drugs for Central Nervous System Diseases Market The global Drugs for Central Nervous System Diseases market size is projected to reac…- ヒト呼吸器合胞体ウイルス薬の世界市場（～2026年） Human respiratory syncytial virus (HRSV) is a syncytial virus that causes respiratory tract infections. It is a major cause of lower respiratory tract infections and hospital visits during infancy and childhood. A prophylactic medication, palivizumab, can be employed to prevent HRSV in preterm (unde…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- 爪囲炎治療薬の世界市場（～2026年） Paronychia usually happens when the skin around an individual's nail is irritated or harmed. Paronychia is a soft tissue infection of the skin around the fingernails and toenails. Bacteria which cause this type of infection are known as Candida. The infection begins as cellulitis but may progress to…
- 免疫療法薬の世界市場（～2026年） Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system. North America is expected to account for largest share in the …